In adults 18 years of age and older, Prevnar 13 is indicated for: active immunization for the prevention of pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.

This vaccine is used to help protect from infection due to a certain bacteria (Streptococcus pneumoniae). This bacteria can cause ear infection or other more serious infections (such as pneumonia, meningitis). Some brands are approved for use only in children, while others can be used in both children and adults.

One dose of PCV13 is recommended for adults: 65 years or older who have not previously received PCV13. 19 years or older with certain medical conditions and who have not previously received PCV13.

Each 0.5 mL dose is to be injected intramuscularly using a sterile needle attached to the supplied prefilled syringe. The preferred sites for injection are the anterolateral aspect of the thigh in infants and the deltoid muscle of the upper arm in toddlers, children and adults.

Who needs pneumococcal vaccines? All adults 65 and older need two pneumococcal shots: the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23). Some adults who are 19 to 64 will need two pneumococcal shots - both PCV13 and PPSV23.

What side effects may I notice from receiving this medication? Side effects that you should report to your doctor or health care professional as soon as possible: allergic reactions (skin rash, itching or hives; swelling of the face, lips, or tongue) confusion.

Side effects that you should report to your doctor or health care professional as soon as possible: allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue. breathing problems.

People who need a pneumonia vaccine should get both shots: first, the PCV13 shot and then the PPSV23 shot a year or more later. For most people, one of each shot should be enough to protect them for their entire lives. Sometimes, you may need a booster shot.

Prevnar 13 is to be administered as a four-dose series at 2, 4, 6, and 12-15 months of age. a Dose 1 may be given as early as 6 weeks of age. b The recommended dosing interval is 4 to 8 weeks. c The fourth dose should be administered at approximately 12-15 months of age, and at least 2 months after the third dose.

People who need a pneumonia vaccine should get both shots: first, the PCV13 shot and then the PPSV23 shot a year or more later. For most people, one of each shot should be enough to protect them for their entire lives.

Site: The deltoid muscle is the preferred location for PCV13/PCV15 vaccination in older children and PCV15/PCV20 vaccination in adults. The preferred injection site for PCV13/PCV15 for infants and young children is vastus lateralis in the anterolateral thigh.

Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. Administer pneumococcal conjugate vaccines (PCV15 and PCV20) intramuscularly. For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. For older children and adults, use the deltoid muscle.